Organization & Developments: Cerevast

Parents

Based on technology created by Dr. Andrei Alexandrov
Cerevast plans to market a patented, innovative, operator-assisted transcranial doppler (TCD) ultrasound device with an initial therapeutic focus in the field of acute ischemic stroke.
ClotBust-ER
Developing a non-invasive treatment for acute ischemic stroke by harnessing acoustic energy from externally applied ultrasound to treat stroke-causing clots in the blood vessels of the brain
Primary emphasis in the field of sonolysis for the treatment of vascular thrombus disorders.
The company’s first product, the Neurosonx™ SR is a Transcranial Ultrasound (TUS) device which transmits ultrasonic energy into the motor cortex region of the brain to promote recovery and rehabilitation from acute stroke.